VanEck Vectors Natural Resource ETF HAP 深 沪
等待开盘 09-08 09:30:00 美东时间
55.24
+0.132
+0.24%
华盛通- 最 高55.50
- 今 开55.41
- 成交量 7439股
- 最 低 55.1214
- 昨 收 55.1076
- 总市值 1.68亿
- 52周最高 55.50
- 市盈率 静 --
- 换手率 0.24%
- 52周最低 42.65
- 委 比 0.00%
- 总股本 305.00万
- 历史最高 55.50
- 量 比 1.66
- 振 幅 0.69%
- 历史最低 12.7848
- 每 手 1
- 风险率 2.45%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Happiest Minds Technologies Celebrates Triple Win at Brandon Hall Awards 2025
An announcement from Happiest Minds Technologies Ltd. ( ($IN:HAPPSTMNDS) ) is n...
09-03 13:13
Happiest Minds Announces Newspaper Publication on Scheme of Arrangement
Happiest Minds Technologies Ltd. ( ($IN:HAPPSTMNDS) ) has provided an announcem...
08-30 00:55
新瀚新材：8月26日接受机构调研，嘉实基金、淳厚基金等多家机构参与
证券之星消息，2025年8月26日新瀚新材（301076）发布公告称公司于2025年8月26日接受机构调研，嘉实基金徐鹤洋、淳厚基金田文天、上海季胜投资刘青林、民生证券刘隆基、东海基金张元涛、上海喜世润投资刘冲力、毕盛(上海)投资骆红永、信诚基金姚思洲、南京证券顾诗园、建信基金吴昂达、正圆私募基金刘家铄、申万宏源李绍程参与。
08-26 19:01
Happy Forgings Limited Releases Q1 FY2026 Monitoring Agency Report
Happy Forging Limited ( ($IN:HAPPYFORGE) ) has shared an update. Happy Forgings...
08-09 17:44
Happiest Minds Seeks Shareholder Approval for Leadership Re-appointments
The latest announcement is out from Happiest Minds Technologies Ltd. ( ($IN:HAP...
08-05 17:56
President Trump Posts On Truth Social "Australia to take U.S. BEEF for first time. A very BIG market. I hope our GREAT FARMERS ARE HAPPY. MAKE AMERICA GREAT AGAIN!!!"
https://trumpstruth.org/statuses/32195
07-25 22:31
Donald Trump Posts On Truth Social "HAPPY CRYPTO WEEK! The House will soon VOTE on a tremendous Bill to Make America the UNDISPUTED, NUMBER ONE LEADER in Digital Assets - Nobody does it better! The GENIUS Act is going to put our Great Nation lightyears ahead of China, Europe, and all others, who are trying endlessly to catch up, but they just can't do it. ..."
https://truthsocial.com/@realDonaldTrump/posts/114857957325423668
07-15 23:32
辉瑞(PFE.US)新型抗菌药物思福诺®在中国获批
智通财经APP获悉，辉瑞公司(PFE.US)今日(6月30日)宣布，新型抗菌药物思福诺®(注射用氨曲南阿维巴坦钠，以下简称“氨曲南/阿维巴坦”)获得国家药品监督...
06-30 11:28
快讯 | 辉瑞新型抗菌药物思福诺在华获批
辉瑞公司6月30日宣布，新型抗菌药物思福诺（注射用氨曲南阿维巴坦钠，以下简称“氨曲南/阿维巴坦”）获得国家药品监督管理局正式批准，用于治疗由革兰阴性菌引起的治疗...
06-30 11:18
